The study sets out how gene expression that drives the formation of new blood vessels exhibits different patterns, cell by cell, in the brains of people with Alzheimer's disease.

Preliminary results of a clinical trial of 4-phenylbutyrate (PBA) “show a significant reduction in seizure activity among participants.”

A new study in Nature identifies research strategies for tying brain function and structure to behavior and health.

Researchers introduce a biomarker to indicate whether someone is struggling with the inflexible thinking associated with the disorder.

Evaluating how genetic risk interacts with environmental risk factors such as sexual trauma is important for understanding how mental illness develops and identifying high-risk groups for early intervention.

Early detection opens the door to intervention via noninvasive neuromodulation for those with treatment-resistant symptoms of psychotic disorders like schizophrenia.

Bodien, who will co-direct the Neuroimaging Core of the Critical Illness, Brain Dysfunction and Survivorship Center, has applied behavioral measures and advanced neuroimaging to improve the diagnosis and prognosis of severe brain injury.